NASDAQ: TRMLTourmaline Bio Inc Stock Ownership - Who owns Tourmaline Bio?
Insider buying vs selling
Have Tourmaline Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sandeep Chidambar Kulkarni | CEO | 2024-08-21 | 1,779 | $14.85 | $26.42kBuy |
| Sandeep Chidambar Kulkarni | CEO | 2024-08-16 | 5,221 | $13.79 | $72.00kBuy |
TRML insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TRML insiders and whales buy or sell their stock.
TRML Shareholders
What type of owners hold Tourmaline Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Suzanne Ildstad | 21.90% | 5,625,597 | $111.95M | Insider |
| Sandip Agarwala | 12.54% | 3,220,775 | $64.09M | Insider |
| Longitude Capital Partners III LLC | 12.54% | 3,220,775 | $64.09M | Insider |
| Ra Capital Management LP | 9.88% | 2,538,925 | $50.52M | Institution |
| Avoro Capital Advisors LLC | 9.44% | 2,425,000 | $48.26M | Institution |
| Blackrock Inc | 6.98% | 1,792,208 | $35.66M | Institution |
| Tcg Crossover Management LLC | 5.75% | 1,477,593 | $29.40M | Institution |
| Qvt Financial LP | 5.74% | 1,473,369 | $29.32M | Institution |
| Pfizer Inc | 4.95% | 1,272,214 | $25.32M | Institution |
| Vanguard Group Inc | 4.64% | 1,190,810 | $23.70M | Institution |
TRML vs Biotech Stocks
Tourmaline Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.